1.
NC Osuji, I Del Giudice, E Matutes, AC Wotherspoon, C Dearden, D Catovsky. The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53. haematol [Internet]. 2005Jan.1 [cited 2022May22];90(10):1435-6. Available from: https://haematologica.org/article/view/3702